<?xml version="1.0"?>
<metadata xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/"><dc:title>Enterovirus D68 circulation between 2014 and 2022 in Slovenian children</dc:title><dc:creator>Uršič,	Tina	(Avtor)
	</dc:creator><dc:creator>Jevšnik Virant,	Monika	(Avtor)
	</dc:creator><dc:creator>Kogoj,	Rok	(Avtor)
	</dc:creator><dc:creator>Krivec,	Uroš	(Avtor)
	</dc:creator><dc:creator>Prusnik,	Joanna	(Avtor)
	</dc:creator><dc:creator>Mramor,	Minca	(Avtor)
	</dc:creator><dc:creator>Lovšin,	Sara	(Avtor)
	</dc:creator><dc:creator>Petrovec,	Miroslav	(Avtor)
	</dc:creator><dc:subject>virologija</dc:subject><dc:subject>enterovirusi</dc:subject><dc:subject>kroženje virusov</dc:subject><dc:subject>pojavnost</dc:subject><dc:description>Introduction: Enterovirus D68 (EV-D68) belongs to the Picornaviridae family, genus Enterovirus. It is mostly known as a respiratory virus causing upper and lower respiratory tract infections, but it is also rarely associated with a variety of central nervous system complications, with acute flaccid myelitis being reported most frequently. This study assesses the incidence, seasonality, clinical presentation, and molecular epidemiology of the EV-D68 strain in EV-positive children hospitalized between 2014 and 2022 at the largest pediatric medical center in Slovenia. 
Methods: EV-D68 was detected using specific qRT-PCR, whereas partial VP1 sequences were obtained with Sanger sequencing, and further analyzed using the software CLC Main Workbench version 7 and MEGA version X. Results: EV-D68 was detected in 154 out of 1,145 (13.4%) EV-positive children. In the two epidemic years, 2014 and 2016, EV-D68 was most frequently detected in the summer and early autumn, peaking in September. The median age of EV-D68–infected children was 3 years (IQR 1–3 years), with a female: male ratio of 1:1.17. Rhinorrhea was present in 74.0% of children, respiratory distress in 82.5%, and hypoxemia requiring supplemental oxygen in 44.1%. Out of 154 patients, 80.0% were hospitalized, with a median stay of 2 days (IQR 1–3 days). Lower respiratory tract infection was observed in 89.0% of EV-D68–positive patients, with bronchitis and bronchiolitis being most frequently diagnosed. No central nervous system manifestations of EV-D68 infection were observed in the study cohort. Phylogenetic analysis of partial VP1 sequences of EV-D68 revealed close similarity to the EV-D68 variants that were circulating in other European countries in these years. 
Discussion: Slovenia faced two EV-D68 epidemics in 2014 and 2016; however, after 2016 only nine more cases were detected until the end of the study period. Based on the results of this study, EV-D68 was a frequent cause of lower respiratory tract infection among EV-positive patients. However, none of the patients we studied needed ICU treatment, and none developed acute flaccid paralysis. Our results indicate that EV-D68 is not present constantly, so additional monitoring studies should be conducted in the future to better understand the implications of this EV type in human disease.</dc:description><dc:date>2024</dc:date><dc:date>2026-06-10 06:32:48</dc:date><dc:type>Članek v reviji</dc:type><dc:identifier>183269</dc:identifier><dc:identifier>UDK: 578</dc:identifier><dc:identifier>ISSN pri članku: 2673-818X</dc:identifier><dc:identifier>DOI: 10.3389/fviro.2024.1335752</dc:identifier><dc:identifier>COBISS_ID: 183095299</dc:identifier><dc:language>sl</dc:language></metadata>
